Published in Cancer Res on April 15, 1995
p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol (2000) 6.23
Gene expression patterns associated with p53 status in breast cancer. BMC Cancer (2006) 2.61
Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc Natl Acad Sci U S A (1995) 2.43
Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids (2010) 1.82
Apoptosis and molecular targeting therapy in cancer. Biomed Res Int (2014) 1.47
Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U S A (2002) 1.45
MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. J Biol Chem (2011) 1.36
Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding. Mol Cell Biol (1998) 1.35
Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res (2010) 1.35
Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53. Proc Natl Acad Sci U S A (2002) 1.32
Targeting p53 for Novel Anticancer Therapy. Transl Oncol (2010) 1.26
p53-mediated protective responses to UV irradiation. Proc Natl Acad Sci U S A (1997) 1.24
Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol Cell Biol (1996) 1.24
Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect (1999) 1.22
DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci U S A (1996) 1.22
p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc Natl Acad Sci U S A (1997) 1.21
P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation. BMC Cancer (2011) 1.18
The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases. Curr Genomics (2010) 1.15
Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. Mol Cancer Ther (2013) 1.08
p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci U S A (1998) 1.08
Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G(1)/S checkpoint activation in response to DNA damage. Proc Natl Acad Sci U S A (2001) 1.08
Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53. Biochem Pharmacol (2011) 1.03
Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene. Mol Cancer Res (2008) 1.02
Cisplatinum and taxol induce different patterns of p53 phosphorylation. Neoplasia (2001) 1.00
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. Br J Cancer (1997) 0.99
p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma. Neoplasia (2006) 0.97
Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents. J Cancer Res Clin Oncol (2003) 0.93
DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1. Nucleic Acids Res (2003) 0.90
Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1. Cancer Biol Ther (2014) 0.89
Tumor suppressor protein p53 negatively regulates human pregnane X receptor activity. Mol Pharmacol (2013) 0.89
The two faces of tumor suppressor p53. Am J Pathol (1996) 0.88
Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation. Br J Cancer (1996) 0.87
Human thyroid cancer cells as a source of iso-genic, iso-phenotypic cell lines with or without functional p53. Br J Cancer (1999) 0.87
ATR-p53 restricts homologous recombination in response to replicative stress but does not limit DNA interstrand crosslink repair in lung cancer cells. PLoS One (2011) 0.85
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer. Oncotarget (2015) 0.85
Mechanisms of resistance to alkylating agents. Cytotechnology (1998) 0.84
Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs. Int J Oncol (2000) 0.84
RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy. Cancer Biol Ther (2014) 0.83
A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance. Cell Death Dis (2013) 0.83
Phenoxodiol protects against Cisplatin induced neurite toxicity in a PC-12 cell model. BMC Neurosci (2007) 0.82
DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells. Biochim Biophys Acta (2012) 0.82
New insights into the kinetic resistance to anticancer agents. Cytotechnology (1998) 0.82
Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines. Invest New Drugs (2000) 0.81
Pharmacogenomics in bladder cancer. Urol Oncol (2014) 0.81
Novel roles for p53 in the genesis and targeting of tetraploid cancer cells. PLoS One (2014) 0.80
Promotion of cell migration by neural cell adhesion molecule (NCAM) is enhanced by PSA in a polysialyltransferase-specific manner. PLoS One (2015) 0.80
The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines. World J Gastroenterol (2004) 0.80
Inhibition of homologous recombination repair with Pentoxifylline targets G2 cells generated by radiotherapy and induces major enhancements of the toxicity of cisplatin and melphalan given after irradiation. Radiat Oncol (2006) 0.79
Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells. PLoS One (2015) 0.79
Driving p53 response to Bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis. Neoplasia (2000) 0.78
Histopathology and Prognostic Indices of Carcinoma Breast with Special Reference to p53 Marker. J Clin Diagn Res (2014) 0.78
Bisindole-PBD regulates breast cancer cell proliferation via SIRT-p53 axis. Cancer Biol Ther (2015) 0.78
Caffeine-mediated override of checkpoint controls. A requirement for rhp6 (Schizosaccharomyces pombe). Genetics (1999) 0.77
The "Two faces" of Tumor Suppressor p53-revisited. Mol Cell Pharmacol (2010) 0.76
Thyroid hormone - triiodothyronine - has contrary effect on proliferation of human proximal tubules cell line (HK2) and renal cancer cell lines (Caki-2, Caki-1) - role of E2F4, E2F5 and p107, p130. Thyroid Res (2008) 0.76
The effect of pentoxifylline on spontaneous and experimental metastasis of the mouse Neuro2a neuroblastoma. Clin Exp Metastasis (1997) 0.76
The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition. PLoS One (2016) 0.75
Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer. Urol Clin North Am (2015) 0.75
In silico assay development for screening of tetracyclic triterpenoids as anticancer agents against human breast cancer cell line MCF7. PLoS One (2014) 0.75
Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer. Medicine (Baltimore) (2016) 0.75
Seleno-L-Methionine Modulation of Nucleotide Excision DNA Repair Relevant to Cancer Prevention and Chemotherapy. Mol Cell Pharmacol (2009) 0.75
Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochim Biophys Acta (2017) 0.75
The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy. PLoS One (2017) 0.75
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell (1992) 19.87
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
An information-intensive approach to the molecular pharmacology of cancer. Science (1997) 11.43
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res (1994) 9.00
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol (2000) 6.23
Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science (1994) 6.11
Repair of gamma-ray-induced DNA base damage in xeroderma pigmentosum cells. Radiat Res (1986) 5.08
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res (1997) 4.34
Conduction at domain walls in oxide multiferroics. Nat Mater (2009) 4.18
The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol (1994) 4.15
The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem (2000) 3.49
Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J (1999) 3.46
Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol (1994) 3.30
Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature (2001) 3.25
Changes in bone density with lactation. JAMA (1993) 3.24
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19
Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J (1999) 3.13
Coding assignments of double-stranded RNA segments of SA 11 rotavirus established by in vitro translation. J Virol (1980) 3.10
Genomic instability in Gadd45a-deficient mice. Nat Genet (1999) 3.01
GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A (1999) 2.80
Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents. J Natl Cancer Inst (1994) 2.78
Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol (1993) 2.77
Bcl-2 family proteins are essential for platelet survival. Cell Death Differ (2007) 2.67
Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem (1997) 2.53
The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol (1984) 2.52
Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med (1997) 2.48
An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res (2000) 2.47
The role of the right hippocampus in the recall of spatial location. Neuropsychologia (1981) 2.45
The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res (1994) 2.41
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J Natl Cancer Inst (1996) 2.39
Neural computing in cancer drug development: predicting mechanism of action. Science (1992) 2.38
Induction of a common pathway of apoptosis by staurosporine. Exp Cell Res (1994) 2.34
Induction of B2 RNA polymerase III transcription by heat shock: enrichment for heat shock induced sequences in rodent cells by hybridization subtraction. Nucleic Acids Res (1986) 2.31
Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene (1999) 2.29
Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand (1984) 2.24
Fractionation of DNA from mammalian cells by alkaline elution. Biochemistry (1976) 2.20
Meta-analysis of psychotherapy outcome studies. Am Psychol (1977) 2.19
Pediatric euthanasia. Am J Dis Child (1992) 2.12
Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene (1999) 2.12
The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. Cell (2000) 2.11
Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res (2000) 2.11
DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res (1979) 2.08
Aspergilli as ochratoxin producers. Mycologia (1972) 2.07
p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res (1998) 2.02
Frontal lobes and the temporal organization of memory. Hum Neurobiol (1985) 2.02
Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene (1995) 2.00
Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Mol Cell Biol (1999) 1.97
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res (1994) 1.94
Enhancement of sympathetic nerve activity by single premature ventricular beats in humans. J Am Coll Cardiol (1989) 1.93
Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci U S A (1993) 1.91
Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene (1994) 1.88
DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature (1980) 1.86
Myc represses the growth arrest gene gadd45. Oncogene (1997) 1.86
Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features. J Neurosurg (2001) 1.85
Mammalian GADD34, an apoptosis- and DNA damage-inducible gene. J Biol Chem (1997) 1.85
Metabolism of ubiquitinated histones. J Biol Chem (1981) 1.83
A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem (1995) 1.82
Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J Biol Chem (1995) 1.80
T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells. Proc Natl Acad Sci U S A (1984) 1.77
X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution. Nucleic Acids Res (1979) 1.76
Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. J Biol Chem (1991) 1.74
Production of aflatoxin on wheat and oats: measurement with a recording densitometer. Appl Microbiol (1967) 1.74
Comparison of prolactin levels in human semen and seminal plasma. J Endocrinol (1979) 1.74
DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. Biochemistry (1996) 1.73
DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Res (1986) 1.72
Response to adversity: molecular control of gene activation following genotoxic stress. New Biol (1991) 1.72
Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. Cancer Res (1989) 1.71
ATP-dependent lysosomal cystine efflux is defective in cystinosis. J Biol Chem (1982) 1.71
Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene (1998) 1.71
Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol Cell Biol (1991) 1.69
Induction of gene expression as a monitor of exposure to ionizing radiation. Radiat Res (2001) 1.69
Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol (2001) 1.66
Rise in sexually transmitted diseases during democratization and economic crisis in Mongolia. Int J STD AIDS (1997) 1.64
A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol Ther (2002) 1.64
Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I. J Biol Chem (1997) 1.63
Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. Biochemistry (1981) 1.63
Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol (1999) 1.62
The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem (2000) 1.62
Regional hippocampal alteration associated with cognitive deficit following experimental brain injury: a systems, network and cellular evaluation. Neuroscience (2005) 1.61
Electric field-induced magnetization switching in epitaxial columnar nanostructures. Nano Lett (2005) 1.61
Analysis of the mammalian gadd45 gene and its response to DNA damage. J Biol Chem (1993) 1.58